6-Chloro-N-(3-((5-methoxyquinolin-2-yl)amino)phenyl)picolinamide

ID: ALA4742970

PubChem CID: 162646274

Max Phase: Preclinical

Molecular Formula: C22H17ClN4O2

Molecular Weight: 404.86

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cccc2nc(Nc3cccc(NC(=O)c4cccc(Cl)n4)c3)ccc12

Standard InChI:  InChI=1S/C22H17ClN4O2/c1-29-19-9-3-7-17-16(19)11-12-21(27-17)24-14-5-2-6-15(13-14)25-22(28)18-8-4-10-20(23)26-18/h2-13H,1H3,(H,24,27)(H,25,28)

Standard InChI Key:  TTZRRNYHGNCFRD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   14.2763  -12.2029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2752  -13.0303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9899  -13.4430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9881  -11.7902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7034  -12.1993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7042  -13.0260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4194  -13.4370    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1344  -13.0223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1296  -12.1923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4138  -11.7852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9852  -10.9654    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.6982  -10.5504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8479  -13.4359    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.5630  -13.0246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2743  -13.4428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9890  -13.0323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9908  -12.2065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2720  -11.7930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5604  -12.2058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7010  -13.4475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.4171  -13.0380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1298  -13.4536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4207  -12.2132    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.1249  -14.2789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8366  -14.6943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5537  -14.2848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5547  -13.4556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8423  -13.0439    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.2704  -13.0470    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  4 11  1  0
 11 12  1  0
  8 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 16 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 22 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 22  1  0
 27 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4742970

    ---

Associated Targets(Human)

Panel NCI-60 (60 carcinoma cell lines) (1088 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLT-4 (49676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPMI-8226 (44974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SR (39847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-92 (41141 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H522 (44358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A498 (42825 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UO-31 (46270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 404.86Molecular Weight (Monoisotopic): 404.1040AlogP: 5.29#Rotatable Bonds: 5
Polar Surface Area: 76.14Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.70CX LogP: 5.09CX LogD: 5.08
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.44Np Likeness Score: -1.39

References

1. El-Damasy AK,Haque MM,Park JW,Shin SC,Lee JS,EunKyeong Kim E,Keum G.  (2020)  2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAF/C-RAF kinase inhibitory effects: Design, synthesis, in vitro cell-based and oncogenic kinase assessments.,  208  [PMID:32942186] [10.1016/j.ejmech.2020.112756]

Source